Plus Therapeutics Files 8-K: Board & Compensation Changes
Ticker: PSTV · Form: 8-K · Filed: Apr 18, 2025 · CIK: 1095981
| Field | Detail |
|---|---|
| Company | Plus Therapeutics, Inc. (PSTV) |
| Form Type | 8-K |
| Filed Date | Apr 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
TL;DR
PLUS THERAPEUTICS just filed an 8-K about board and exec comp changes - watch for updates.
AI Summary
On April 18, 2025, PLUS THERAPEUTICS, INC. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the election of new directors and potential adjustments to compensatory arrangements for certain officers, effective as of April 17, 2025.
Why It Matters
Changes in a company's board of directors and executive compensation can signal shifts in strategy, governance, or financial outlook, potentially impacting investor confidence and stock performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts that may affect future performance or strategy.
Key Players & Entities
- PLUS THERAPEUTICS, INC. (company) — Registrant
- April 18, 2025 (date) — Filing Date
- April 17, 2025 (date) — Effective Date of Changes
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of directors, but the specific names and details of the changes are not provided in the excerpt.
Are there any details on the new compensatory arrangements for officers?
The filing mentions 'Compensatory Arrangements of Certain Officers' as an item, but the specific details of these arrangements are not included in the provided text.
What was the previous name of Plus Therapeutics, Inc.?
Plus Therapeutics, Inc. was formerly known as CYTORI THERAPEUTICS, INC. and prior to that, MACROPORE INC.
When did the company last change its name?
The company's name was last changed from CYTORI THERAPEUTICS, INC. on July 12, 2005.
What is the principal executive office address for Plus Therapeutics, Inc.?
The principal executive offices are located at 2710 Reed Road, Suite 160, Houston, Texas 77051.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 18, 2025 regarding PLUS THERAPEUTICS, INC. (PSTV).